Search research articles
Contact Us
Filters
Showing results (131-140 of 232) with videos related to
Page
of 24
Sort By:
Neuro-Oncology
|
June 3, 2026
Spatial dissection of ADC/RPT targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumors
Nic G Reitsam, Victoria E Fincke, Maria Daniela Hernandez Ramirez, et al.
Acta Neuropathologica
|
July 1, 2026
Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes
Lea Altendorf, Anton Althammer, Rajanya Roy, et al.
Oncotarget
|
December 10, 2015
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
Somayyeh Fahiminiya, Leora Witkowski, Javad Nadaf, et al.
Molecular Cell
|
November 5, 2021
Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks
Amel Chaouch, Johannes Berlandi, Carol C L Chen, et al.
Pharmacological Research
|
February 17, 2025
An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT)
David Pauck, Daniel Picard, Mara Maue, et al.
Acta Neuropathologica
|
January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler, David Capper, Jochen Meyer, et al.
The Journal of Clinical Investigation
|
July 12, 2005
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis
Armin Schneider, Carola Krüger, Tobias Steigleder, et al.
Neuro-Oncology Advances
|
August 26, 2024
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation
Patrick N Harter, Katharina J Weber, Franz L Ricklefs, et al.
Pediatric Blood & Cancer
|
June 2, 2025
Malignant Rhabdoid Tumors of Cranial Nerves-A Clinically Distinct Group With Characteristic Neuroradiological, Histopathological, and Molecular Features
Miriam Gruhle, Brigitte Bison, Katharina Gastberger, et al.
Brain Pathology (Zurich, Switzerland)
|
February 5, 2017
Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course
Katharina Heß, Jan Purrucker, Ute Hegenbart, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 232) with videos related to
Sort By:
Page
of 24
Neuro-Oncology
|
June 3, 2026
Spatial dissection of ADC/RPT targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumors
Nic G Reitsam, Victoria E Fincke, Maria Daniela Hernandez Ramirez, et al.
Acta Neuropathologica
|
July 1, 2026
Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes
Lea Altendorf, Anton Althammer, Rajanya Roy, et al.
Oncotarget
|
December 10, 2015
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
Somayyeh Fahiminiya, Leora Witkowski, Javad Nadaf, et al.
Molecular Cell
|
November 5, 2021
Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks
Amel Chaouch, Johannes Berlandi, Carol C L Chen, et al.
Pharmacological Research
|
February 17, 2025
An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT)
David Pauck, Daniel Picard, Mara Maue, et al.
Acta Neuropathologica
|
January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler, David Capper, Jochen Meyer, et al.
The Journal of Clinical Investigation
|
July 12, 2005
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis
Armin Schneider, Carola Krüger, Tobias Steigleder, et al.
Neuro-Oncology Advances
|
August 26, 2024
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation
Patrick N Harter, Katharina J Weber, Franz L Ricklefs, et al.
Pediatric Blood & Cancer
|
June 2, 2025
Malignant Rhabdoid Tumors of Cranial Nerves-A Clinically Distinct Group With Characteristic Neuroradiological, Histopathological, and Molecular Features
Miriam Gruhle, Brigitte Bison, Katharina Gastberger, et al.
Brain Pathology (Zurich, Switzerland)
|
February 5, 2017
Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course
Katharina Heß, Jan Purrucker, Ute Hegenbart, et al.
Page
of 24